Lipopolysaccharide animal models of Parkinson's disease: Recent progress and relevance to clinical disease - ScienceDirect
Is Porphyromonas gingivalis involved in Parkinson's disease? | SpringerLink
IJMS | Free Full-Text | Licochalcone A Prevents the Loss of Dopaminergic Neurons by Inhibiting Microglial Activation in Lipopolysaccharide (LPS)-Induced Parkinson's Disease Models
The Synergy of Aging and LPS Exposure in a Mouse Model of Parkinson's Disease
![PDF] Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/40b2123121854064d06277f761d5ca441fa15fd2/6-Figure2-1.png "PDF] Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons | Semantic Scholar")
PDF] Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons | Semantic Scholar
Neuronal Mitochondria Modulation of LPS-Induced Neuroinflammation | Journal of Neuroscience
Frontiers | Review: The Role of Intestinal Dysbiosis in Parkinson's Disease
The Endotoxin-Induced Neuroinflammation Model of Parkinson's Disease
LPS induces chronic neuroinflammation with heterogeneous densities of... | Download Scientific Diagram
Intranasal LPS-Mediated Parkinson's Model Challenges the Pathogenesis of Nasal Cavity and Environmental Toxins | PLOS ONE
Parkinson's Disease-Related Proteins PINK1 and Parkin Repress Mitochondrial Antigen Presentation: Cell
Neuropharmacology Group - Neuron-glia Interactons
Impact of Aging and Gut Microbiota on Neuroinflammation and Parkinson's Disease | PerkinElmer
Experimental Neurobiology
Lipopolysaccharide animal models of Parkinson's disease: Recent progress and relevance to clinical disease - ScienceDirect
Salidroside ameliorates Parkinson's disease by inhibiting NLRP3-dependent pyroptosis - Figure f10 | Aging
The Synergy of Aging and LPS Exposure in a Mouse Model of Parkinson's Disease
Neuroprotective Effect of Swertiamarin in a Rotenone Model of Parkinson's Disease: Role of Neuroinflammation and Alpha-Synuclein Accumulation | ACS Pharmacology & Translational Science
MicroRNA‐3473b regulates the expression of TREM2/ULK1 and inhibits autophagy in inflammatory pathogenesis of Parkinson disease - Lv - 2021 - Journal of Neurochemistry - Wiley Online Library
Synergistic Dopaminergic Neurotoxicity of the Pesticide Rotenone and Inflammogen Lipopolysaccharide: Relevance to the Etiology of Parkinson's Disease | Journal of Neuroscience
Characterization of the lipopolysaccharide induced model of Parkinson's disease: Role of oxidative stress and neuroinflammation - ScienceDirect
Parkinson's disease: Are gut microbes involved? | American Journal of Physiology-Gastrointestinal and Liver Physiology
Lipopolysaccharide animal models of Parkinson's disease: Recent progress and relevance to clinical disease - ScienceDirect
Frontiers | The Gut–Brain Axis and Its Relation to Parkinson's Disease: A Review
Osmotin attenuates LPS-induced neuroinflammation and memory impairments via the TLR4/NFκB signaling pathway | Scientific Reports
IJMS | Free Full-Text | Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice
Urate inhibits microglia activation to protect neurons in an LPS-induced model of Parkinson's disease | Journal of Neuroinflammation | Full Text
Parkinson's disease: a systemic inflammatory disease accompanied by bacterial inflammagens | bioRxiv
